KIORA PHARMACEUTICALS, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-06-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2017-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $0.00.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2017 was $0.00.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- KIORA PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2015 was $36.41M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $0.00 10-K · filed 2025-03-25 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-09 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $0.00 10-K · filed 2019-03-01 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $0.00 10-K · filed 2018-03-02 |
| 2015-12-31 | $72.82M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $36.41M 10-K · filed 2017-02-23 |
| 2015-09-30 | -$72.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | |
| 2015-03-31 | $36.41M 10-Q · filed 2015-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |